Shares in Tekmira Pharmaceutical, a Canadian drug company that is developing a potential treatment for Ebola, are expected to be active Wednesday after a case of the deadly disease was reported in the U.S.
MarketWatch.com - Top Stories, MarketWatch
Wed, 10/01/2014 - 2:30am
Shares in Tekmira Pharmaceutical, a Canadian drug company that is developing a potential treatment for Ebola, are expected to be active Wednesday after a case of the deadly disease was reported in the U.S.